Novartis: ‘Europe lags behind, priority to US investments’
Keystone-SDA
Novartis CEO Vasant Narasimhan told Bloomberg in an interview that he sees clear differences between Europe and the US in the Swiss pharmaceutical giant’s investment strategy.
+ Get the most important news from Switzerland in your inbox
The investment environment outside Europe is currently “much more favourable”, Narasimhan said in the interview with Bloomberg on the sidelines of the World Economic Forum in Davos.
The statement comes against a backdrop of renewed geopolitical uncertainties and trade tensions, challenges that are particularly relevant for an industry with innovation cycles in excess of ten years. Although these “instabilities” should not be underestimated, according to Narasimhan they do not undermine Novartis’ business model.
More
More
US ‘strikes price cut deal’ with Swiss pharma giants
It is counterproductive to adopt a reactionary behaviour to events now, the executive argued. Novartis’ strategy remains to pursue innovation and seek acquisitions to strengthen its portfolio, while maintaining a “very active profile in the transaction market”, as it did last year.
The most direct criticism, however, is reserved for Europe. “It seems that Europe prefers to cling to old industries and subsidies, for example in agriculture, rather than focus on innovative technologies,” noted the American manager with Indian roots. This is why Novartis plans to expand investments mainly in the US, calling the American approach more future-oriented.
Translated from Italian by AI/jdp
We select the most relevant news for an international audience and use automatic translation tools to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication.
Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
If you have any questions about how we work, write to us at english@swissinfo.ch
